Thomas Davis - Apr 4, 2022 Form 4 Insider Report for GENOCEA BIOSCIENCES, INC. (GNCA)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Diantha Duvall, Attorney-in-Fact for Thomas Davis
Stock symbol
GNCA
Transactions as of
Apr 4, 2022
Transactions value $
-$1,364
Form type
4
Date filed
4/5/2022, 08:17 AM
Previous filing
Mar 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNCA Common Stock Sale -$1.36K -1.09K -1.57% $1.25 68.3K Apr 4, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person.